30 under 30: Designing New Ways to Stop Tumors

Meet Nadja Bertleff, one of the promising young chemists attending the 2013 Lindau Nobel Laureate Meeting

Join Our Community of Science Lovers!

Each year hundreds of the best and brightest researchers gather in Lindau, Germany, for the Nobel Laureate Meeting. There, the newest generation of scientists mingles with Nobel Prize winners and discusses their work and ideas. The 2013 meeting is dedicated to chemistry and will involve young researchers from 78 different countries. In anticipation of the event, which will take place from June 30 through July 5, we are highlighting a group of attendees under 30 who represent the future of chemistry. The following profile is the 16th in a series of 30.

Name: Nadja Bertleff
Age: 27
Born: Heidelberg, Germany
Nationality: German

Current position: PhD student at the Institute for Organic Chemistry at the University of Würzburg in Germany
Education: Master’s degree in chemistry from the University of Würzburg


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


What is your field of research?
I am designing and synthesizing carbohydrate-based inhibitors for the tumor-associated protein galectin-1. My research project is highly interdisciplinary and includes techniques from organic synthesis, biochemistry, protein crystallization, and computational chemistry.

What drew you to chemistry, and to that research area in particular?
Early on, I was inspired by renowned research centers such as the European Molecular Biology Laboratory and the German Cancer Research Center, both in Heidelberg, my birthplace. I became fascinated by biological and physiological processes on a molecular level and by the idea of better understanding these complex events. From the chemist’s perspective, the design and synthesis of tailor-made compounds to address and interfere with the severe malfunctions inherent in diseases seemed enormously challenging. I enjoy working at the intersection of chemistry, biology and medicine in my current position. I also benefit greatly from discussions and collaborations with colleagues from diverse scientific backgrounds.

Where do you see yourself in 10 years?
I hope that I will continue to work in a stimulating atmosphere with people around me that inspire and encourage me to question complex issues. In 10 years I see myself leading my own group in an interdisciplinary research center and working on the biggest life science questions of our generation.

Who are your scientific heroes?
I look up to scientists who pursue their research with enthusiasm, who are open-minded for new ideas and techniques, who inspire young fellows, and are socially responsible. Linus Pauling is one of these heroes, and I admire his contributions to the nature of the chemical bond and elucidation of its structure as well as his activism against war and nuclear weapons tests.

What activities outside of chemistry do you most enjoy?
I love to travel around the world and discover new places. The most impressive experiences I’ve had were touring New Zealand in a camper and traveling through the volcanic and glacier-covered landscape of Iceland.

What do you hope to gain from this year’s Lindau meeting?
In Lindau I will meet investigators that were awarded with the most renowned prize in science—the Nobel Prize! I am excited to learn more about their research, obstacles and successes in their academic careers. I am extremely curious about their predictions on how research will develop in the future and how scientific responsibility should be practiced. I am looking forward to the stimulating and inspiring atmosphere in Lindau and to fruitful discussions with like-minded young scientists. I am convinced this event will help me to plan my next upcoming career step: a postdoctoral stay abroad.

Are there any Nobelists whom you are particularly excited to meet?
Aaron Ciechanover and Richard Ernst. It will be exciting to meet a Nobelist who does research in a field that is very close to my own project. I am looking forward to Aaron Ciechanover’s talk about drug development in the 21st century. Richard Ernst made outstanding contributions to the field of nuclear magnetic resonance spectroscopy—an analytic tool I use every day for determining the structure of synthetic compounds and macromolecules such as proteins.

 

« Previous 15. Vijay Chudasama

30 Under 30: Lindau Nobel Laureate Meeting

Next » 17. Magnus Johnson

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe